Antipsychotic use patterns in persons initially treated with mood stabilizers: A naturalistic study

Pharmacopsychiatry

Volumn 43, Issue 1, 2010, Pages 17-23

  Verdoux, H ^a   Cougnard, A ^a   Auleley, G R ^b,c   Deligne, J ^b   Blum Boisgard, C ^b   Begaud B ^a   Tournier, M ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b Direction du Service Médical National   (France)

^c INSTITUT NATIONAL DU CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; DROPERIDOL; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; LOXAPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; OXCARBAZEPINE; PENFLURIDOL; PERICIAZINE; PERPHENAZINE; PIMOZIDE; PIPAMPERONE; PIPOTIAZINE; RISPERIDONE; SULPIRIDE; SULTOPRIDE; TIAPRIDE; VALPROATE SEMISODIUM; VALPROMIDE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; COMBINATION CHEMOTHERAPY; DRUG USE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT DURATION;

ADULT; AGED; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; COHORT STUDIES; DEPRESSION; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PHYSICIAN'S PRACTICE PATTERNS; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES;

EID: 76249129089     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0029-1237396     Document Type: Article

References (27)

1. Aparasu RR, Bhatara V, Gupta S. U. S. national trends in the use of antipsychotics during office visits, 19982002. Ann Clin Psychiatry 2005 17 147-152
2. Ashcroft DM, Frischer M, Lockett J, et al. Variations in prescribing atypical antipsychotic drugs in primary care: cross-sectional study. Pharmacoepidemiol Drug Saf 2002 11 285-289
3. Baldessarini RJ, Leahy L, Arcona S, et al. Patterns of psychotropic drug prescription for U. S. patients with diagnoses of bipolar disorders. Psychiatr Serv 2007 58 85-91
4. Bauer MS, Mitchner L. What is a mood stabilizer? An evidence-based response. Am J Psychiatry 2004 161 3-18
5. Bellantuono C, Barraco A, Rossi A, et al. The management of bipolar mania: a national survey of baseline data from the EMBLEM study in Italy. BMC Psychiatry 2007 7 33
6. Berghofer A, Alda M, Adli M, et al. Long-term effectiveness of lithium in bipolar disorder: A multicenter investigation of patients with typical and atypical features. J Clin Psychiatry 2008 69 1860-1868
7. Caceres MC, Penas-Lledo EM, de la Rubia A, et al. Increased use of second generation antipsychotic drugs in primary care: potential relevance for hospitalizations in schizophrenia patients. Eur J Clin Pharmacol 2008 64 73-76
8. Crismon ML, Argo T, SD B, et al. Texas Medication Algorithm Project. Bipolar Disorder Algorithms Procedural Manual Texas Department of State Health Services 2007
9. Essock SM, Covell NH, Davis SM, et al. Effectiveness of switching antipsychotic medications. Am J Psychiatry 2006 163 2090-2095
10. Garver D, Lazarus A, Rajagopalan K, et al. Racial differences in medication switching and concomitant prescriptions in the treatment of bipolar disorder. Psychiatr Serv 2006 57 666-672
11. Ghaemi SN, Hsu DJ, Thase ME, et al. Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants. Psychiatr Serv 2006 57 660-655
12. Kaye JA, Bradbury BD, Jick H. Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study. Br J Clin Pharmacol 2003 56 569-575
13. Li J, McCombs JS, Stimmel GL. Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) program. J Affect Disord 2002 71 131-139
14. Maj M. The impact of lithium prophylaxis on the course of bipolar disorder: A review of the research evidence. Bipolar Disord 2000 2 93-101
15. NICE: Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care in Clinical Guideline No 38 National Institute for Health and Clinical Excellence 2006
16. Russo P, Smith MW, Dirani R, et al. Pharmacotherapy patterns in the treatment of bipolar disorder. Bipolar Disord 2002 4 366-377
17. Sankaranarayanan J, Puumala SE. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 19962003: national estimates and associated factors. Clin Ther 2007 29 723-741
18. Sernyak MJ, Griffin RA, Johnson RM, et al. Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. Am J Psychiatry 1994 151 133-135
19. Stata Statistical Software. Release 9.0. College Station Texas, Stata Corporation 2005
20. Taylor M, Shajahan P, Lawrie SM. Comparing the use and discontinuation of antipsychotics in clinical practice: an observational study. J Clin Psychiatry 2008 69 240-245
21. Tondo L, Baldessarini RJ, Floris G. Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders. Br J Psychiatry Suppl 2001 41 S184-S190
22. Tschoner A, Engl J, Rettenbacher M, et al. Effects of six second generation antipsychotics on body weight and metabolism risk assessment and results from a prospective study. Pharmacopsychiatry 2009 42 29-34
23. Verdoux H, Gonzales B, Takei N, et al. A survey of prescribing practice of antipsychotic maintenance treatment for manic-depressive outpatients. J Affect Disord 1996 38 81-87
24. Verdoux H, Tournier M. Trends in costs of antipsychotics in France. Eur Psychiatry 2009 24 214-215
25. Weinbrenner S, Assion HJ, Stargardt T, et al. Drug prescription patterns in schizophrenia outpatients: analysis of data from a German health insurance fund. Pharmacopsychiatry 2009 42 66-71
26. Weissman EM. Antipsychotic prescribing practices in the Veterans Healthcare Administration New York metropolitan region. Schizophr Bull 2002 28 31-42
27. Yatham LN, Kennedy SH, ODonovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disord 2006 8 721-739